Home

Kabra Drugs Ltd Quarterly Result

Image

Kabra Drugs Ltd

NSE: KABRADRUGS

Net Profit - Last Quarter

₹ -0.54 Cr.

Last updated on: Feb 23, 2025

Kabra Drugs Ltd Quarterly Results Key Highlights

  • The revenue of Kabra Drugs Ltd for the Dec '24 is ₹ 0 crore as compare to the Sep '24 revenue of ₹ 0 crore.
  • This represent the decline of 0%a1# The ebitda of Kabra Drugs Ltd for the Dec '24 is ₹ -0.53 crore as compare to the Sep '24 ebitda of ₹ -0.4 crore.
  • This represent the growth of 32.5%a1# The net profit of Kabra Drugs Ltd for the Dec '24 is ₹ -0.54 crore as compare to the Sep '24 net profit of ₹ -0.4 crore.
  • This represent the growth of 35%a1#.

Kabra Drugs Ltd Quarterly Results Analysis

Market Price of Kabra Drugs Ltd

1M

1Y

3Y

5Y

Monitoring Kabra Drugs Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
17 Feb 202510.56
10 Feb 202510.56
03 Feb 202510.06
27 Jan 202510.06
20 Jan 202510.06
13 Jan 202510.06
30 Dec 202410.06
23 Dec 202410.06
16 Dec 202410.06
09 Dec 20249.59

Historical Revenue of Kabra Drugs Ltd

No data available

* All values are in crore

Historical EBITDA of Kabra Drugs Ltd

No data available

* All values are in crore

Historical Net Profit of Kabra Drugs Ltd

No data available

* All values are in crore

Kabra Drugs Ltd News Hub

Kabra Drugs reports standalone net loss of Rs 0.55 crore in the June 2024 quarter

Net Loss of Kabra Drugs reported to Rs 0.55 crore in the quarter ended June 2024 as against net loss

Read more

16 Aug 24

Kabra Drugs announces board meeting date

Kabra Drugs will hold a meeting of the Board of Directors of the Company on 14 August 2024. Powered

Read more

09 Aug 24

Kabra Drugs to consider Fund Raising

Kabra Drugs will hold a meeting of the Board of Directors of the Company on 4 November 2024. Powered

Read more

22 Oct 24

Kabra Drugs to conduct board meeting

Kabra Drugs will hold a meeting of the Board of Directors of the Company on 2 September 2024. Powere

Read more

28 Aug 24

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Quarterly Results of Kabra Drugs Ltd

What key financial metrics are included in Kabra Drugs Ltd's quarterly results?

Key financial metrics in Kabra Drugs Ltd's quarterly results typically include revenue, net profit, earnings per share (EPS), and operating margins. Other metrics might include cash flow, operating expenses, and client metrics.

When does Kabra Drugs Ltd announce its quarterly results?

Kabra Drugs Ltd usually announces its quarterly results around mid-July for Q1, mid-October for Q2, mid-January for Q3, and mid-April for Q4, aligning with the end of each fiscal quarter. However, different finance companies have their respective schedules for announcing their quarterly results.

How does Kabra Drugs Ltd's quarterly performance impact its stock price?

Kabra Drugs Ltd's quarterly performance can lead to stock price volatility, with strong results often driving the price up, while disappointing results can cause it to drop. Investor sentiment and market expectations also play significant roles.

What is the impact of Kabra Drugs Ltd's quarterly results on dividends?

The impact of Kabra Drugs Ltd's quarterly results on dividends can influence dividend decisions, with strong performance potentially leading to increased or special dividends, while weaker results might result in stable or reduced dividends.

Are there any special announcements usually made during Kabra Drugs Ltd's quarterly results?

Yes, Kabra Drugs Ltd often makes special announcements during its quarterly results, including strategic updates, key client wins, and major contract renewals. They might also guide future performance and share insights on industry trends. These updates are typically highlighted in their press release. However, special announcements made during quarterly results may vary from company to company.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions